Inequalities in receipt of mental and physical healthcare in people with dementia in the UK

Age and Ageing

Volumn 46, Issue 3, 2017, Pages 393-400

  Cooper, Claudia ^a   Lodwick, Rebecca ^b   Walters, Kate ^b   Raine, Rosalind ^b   Manthorpe, Jill ^c   Iliffe, Steve ^b,d   Petersen, Irene ^b  

^a CAMDEN AND ISLINGTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UK Dementias and Neurodegenerative Diseases Research Network   (United Kingdom)

Author keywords

Dementia; Deprivation; Equalities; Healthcare disparities; Medication; Older people; Psychotropic drugs

Indexed keywords

ANXIOLYTIC AGENT; DONEPEZIL; GALANTAMINE; HYPNOTIC AGENT; MEMANTINE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; RIVASTIGMINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; COHORT ANALYSIS; COMPARATIVE STUDY; CONSULTATION; CONTROLLED STUDY; DEMENTIA; DOCUMENTATION; FEMALE; GENDER; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; MONITORING; PHYSICAL HEALTHCARE; PRESCRIPTION; PRIORITY JOURNAL; SOCIAL ISOLATION; UNITED KINGDOM; WEIGHT MONITORING; ANTHROPOMETRY; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; ELDERLY CARE; GERIATRIC ASSESSMENT; HEALTH CARE DISPARITY; INTEGRATED HEALTH CARE SYSTEM; MENTAL HEALTH SERVICE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PATIENT REFERRAL; PRIMARY HEALTH CARE; PSYCHOLOGY; SEX FACTOR; SOCIOECONOMICS; SURGERY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BLOOD PRESSURE DETERMINATION; BODY WEIGHT; DELIVERY OF HEALTH CARE, INTEGRATED; DEMENTIA; FEMALE; GERIATRIC ASSESSMENT; HEALTH SERVICES FOR THE AGED; HEALTHCARE DISPARITIES; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; PRIMARY HEALTH CARE; PSYCHOTROPIC DRUGS; REFERRAL AND CONSULTATION; SEX FACTORS; SOCIOECONOMIC FACTORS; SURGICAL PROCEDURES, OPERATIVE; UNITED KINGDOM;

EID: 85019177006     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afw208     Document Type: Article

References (34)

1. Poblador-Plou B, Calderon-Larranaga A, Marta-Moreno J et al. Comorbidity of dementia: a cross-sectional study of primary care older patients. BMC Psychiatry 2014; 14:84.
2. Laitinen ML, Bell JS, Lavikainen P, Lonnroos E, Sulkava R, Hartikainen S. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland. Int Psychogeriatr 2011; 23(10):1623-31.
3. Schulze J, Glaeske G, van den Bussche H et al. Prescribing of antipsychotic drugs in patients with dementia: a comparison with age-matched and sex-matched non-demented controls. Pharmacoepidemiol Drug Saf 2013; 22(12):1308-16.
4. Barnes TR, Banerjee S, Collins N, Treloar A, McIntyre SM, Paton C. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry 2012; 201(3):221-6.
5. Luppa M, Luck T, Braehler E, Koenig HH, Riedel-Heller SG. Prediction of institutionalisation in dementia - A systematic review. Dementia and geriatric cognitive disorders 2008; 26 (1):65-78
6. Bordier L, Doucet J, Boudet J, Bauduceau B. Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes Metab 2014; 40(5):331-7.
7. Ballard C, Margallo-Lana M, Juszczak E et al. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. Br Med J 2005; 330(7496):874-7.
8. Langballe EM, Engdahl B, Nordeng H, Ballard C, Aarsland D, Selbaek G. Short-and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study. Am J Geriatr Psychiatry 2014 Apr; 22(4):321-31.
9. Sterke CS, van Beeck EF, van d Velde N et al. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol 2012; 52(6):947-55.
10. Bierman EJM, Comijs HC, Gundy CM, Sonnenberg C, Jonker C, Beekman ATF. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent? Int J Geriatr Psychiatry 2007; 22(12):1194-200.
11. Rosenberg PB, Mielke MM, Han D et al. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. Int J Geriatr Psychiatry 2012 Dec; 27(12):1248-57.
12. Medicines and Healthcare products Regulatory Agency CoHM. Antipsychotics: use in elderly people with dementia. Drug Saf Update 2009; 2: 8.
13. Banerjee S The Use of Antipsychotic Medication for People with Dementia: Time for Action. London: Department of Health, 2009.
14. Martinez C, Jones RW, Rietbrock S. Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open 2013; 3(1):e002080.
15. Guthrie B, Clark SA, Reynish EL, McCowan C, Morales DR. Differential impact of two risk communications on antipsychotic prescribing to people with dementia in Scotland: segmented regression time series analysis 2001-2011. PLoS One 2013; 8(7):e68976.
16. McIlroy G, Thomas SK, Coleman JJ. Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing. J Public Health (Oxf) 2015; 37(2):346-52.
17. Hart JT. Inverse care law. Lancet 1971; 1(7696):405-&.
18. Cooper C, Lodwick R, Walters K et al. Observational cohort study: deprivation and access to anti-dementia drugs in the UK. Age Ageing 2016; 45(1):148-54.
19. Booth N. What are the Read Codes? Health Libr Rev 1994; 11: 177-82.
20. Horsfall L, Walters K, Petersen I. Identifying periods of acceptable computer usage in primary care research databases. Pharmacoepidemiol Drug Saf 2013; 22(1):64-9.
21. Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf 2009; 18(1):76-83.
22. Dave S, Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf 2009; 18(8):704-7.
23. Townsend P, Phillimore, M, Beattie A Health and Deprivation: Inequality and the North. London: Croom Helm, 1988.
24. Health and social care information centre. Dementia rule set. Health and social care information centre 2014Available from: URL: http://www.hscic.gov.uk/media/15374/Dementiarulesetv300/ pdf/Dementia_ruleset_v30.0.pdf
25. Brilleman SL, Salisbury C. Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study. Fam Pract 2013; 30(2):172-8.
26. Shah SM, Carey IM, Harris T, DeWilde S, Cook DG. Antipsychotic prescribing to older people living in care homes and the community in England and Wales. Int J Geriatr Psychiatry 2011; 26(4):423-34.
27. Livingston G, Kelly L, Lewis-Holmes E et al. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia. Health Technol Assess 2014; 18(39):1-vi.
28. McBride D, Hardoon S, Walters K, Gilmour S, Raine R. Explaining variation in referral from primary to secondary care: cohort study. Br Med J 2010: 341.
29. Collerton J, Davies K, Jagger C et al. Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ 2009; 339: b4904.
30. Office of National Statistics. Living alone in England and Wales. Office of National Statistics 2015. Available from: URL: http://www.ons.gov.uk/ons/rel/census/2011-census-analysis/ do-the-demographic-and-socio-economic-characteristics-ofthose-living-alone-in-england-and-wales-differ-from-the-generalpopulation-/ sty-living-alone-in-the-uk.html (10 October 2015, date last accessed).
31. Cooper C, Bebbington P et al. The treatment of common mental disorders across age groups: Results from the 2007 adult psychiatric morbidity survey. J Affect Disord 2010; 127(1-3):96-101.
32. Marston L, Nazareth I, Petersen I, Walters K, Osborn DP. Prescribing of antipsychotics in UK primary care: a cohort study. BMJ Open 2014; 4(12):e006135.
33. Feldman L, Wilcock J, Thuné-Boyle I, Iliffe S. Explaining the effects of symptom attribution by carers on help-seeking for individuals living with dementia. Dementia 1471301215593185, first published on June 30, 2015. doi:10.1177/1471301215593185.
34. McCann M, Donnelly M, O'Reilly D. Living arrangements, relationship to people in the household and admission to care homes for older people. Age Ageing 2011 May; 40(3):358-63.